These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 32100883)

  • 1. Loss of p62 impairs bone turnover and inhibits PTH-induced osteogenesis.
    Agas D; Amaroli A; Lacava G; Yanagawa T; Sabbieti MG
    J Cell Physiol; 2020 Oct; 235(10):7516-7529. PubMed ID: 32100883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous parathyroid hormone-related protein compensates for the absence of parathyroid hormone in promoting bone accrual in vivo in a model of bone marrow ablation.
    Zhu Q; Zhou X; Zhu M; Wang Q; Goltzman D; Karaplis A; Miao D
    J Bone Miner Res; 2013 Sep; 28(9):1898-911. PubMed ID: 23716486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disruption of LRP6 in osteoblasts blunts the bone anabolic activity of PTH.
    Li C; Xing Q; Yu B; Xie H; Wang W; Shi C; Crane JL; Cao X; Wan M
    J Bone Miner Res; 2013 Oct; 28(10):2094-108. PubMed ID: 23609180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parathyroid hormone-induced bone resorption does not occur in the absence of osteopontin.
    Ihara H; Denhardt DT; Furuya K; Yamashita T; Muguruma Y; Tsuji K; Hruska KA; Higashio K; Enomoto S; Nifuji A; Rittling SR; Noda M
    J Biol Chem; 2001 Apr; 276(16):13065-71. PubMed ID: 11278791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p62/sequestosome 1 deficiency accelerates osteoclastogenesis
    Zach F; Polzer F; Mueller A; Gessner A
    J Biol Chem; 2018 Jun; 293(24):9530-9541. PubMed ID: 29555685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulatory mechanisms of osteoblast and osteoclast differentiation.
    Katagiri T; Takahashi N
    Oral Dis; 2002 May; 8(3):147-59. PubMed ID: 12108759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasorin as an actor of bone turnover?
    Andrique C; Bonnet AL; Dang J; Lesieur J; Krautzberger AM; Baroukh B; Torrens C; Sadoine J; Schmitt A; Rochefort GY; Bardet C; Six I; Houillier P; Tharaux PL; Schrewe H; Gaucher C; Chaussain C
    J Cell Physiol; 2024 Jun; 239(6):e31257. PubMed ID: 38504496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Parathyroid hormone : its anabolic action on bone].
    Ezura Y; Noda M
    Clin Calcium; 2013 Feb; 23(2):203-9. PubMed ID: 23354087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postnatal deletion of β-catenin in osterix-expressing cells is necessary for bone growth and intermittent PTH-induced bone gain.
    Yu C; Xuan M; Zhang M; Yao Q; Zhang K; Zhang X; Guo J; Song L
    J Bone Miner Metab; 2018 Sep; 36(5):560-572. PubMed ID: 29124436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD109 deficiency induces osteopenia with an osteoporosis-like phenotype in vivo.
    Mii S; Hoshino A; Enomoto A; Murakumo Y; Ito M; Yamaguchi A; Takahashi M
    Genes Cells; 2018 Jul; 23(7):590-598. PubMed ID: 29767469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Development, physiology, and cell activity of bone].
    de Baat P; Heijboer MP; de Baat C
    Ned Tijdschr Tandheelkd; 2005 Jul; 112(7):258-63. PubMed ID: 16047964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human trabecular bone-derived osteoblasts support human osteoclast formation in vitro in a defined, serum-free medium.
    Atkins GJ; Kostakis P; Welldon KJ; Vincent C; Findlay DM; Zannettino AC
    J Cell Physiol; 2005 Jun; 203(3):573-82. PubMed ID: 15573398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of phosphatidylinositol-4-phosphate 5-kinase type-1 gamma (Pip5k1c) in mesenchymal stem cells leads to osteopenia by impairing bone remodeling.
    Yan Q; Gao H; Yao Q; Ling K; Xiao G
    J Biol Chem; 2022 Mar; 298(3):101639. PubMed ID: 35090892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. c-Src-Dependent and -Independent Functions of Matk in Osteoclasts and Osteoblasts.
    Kim JH; Kim K; Kim I; Seong S; Kim N
    J Immunol; 2018 Apr; 200(7):2455-2463. PubMed ID: 29440352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Biological function of bone cells on the PTH-driven anabolic effect].
    Hasegawa T; Hongo H; Sasaki M; Yamada T; Amizuka N
    Clin Calcium; 2012 Mar; 22(3):373-9. PubMed ID: 22370304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow ablation demonstrates that excess endogenous parathyroid hormone plays distinct roles in trabecular and cortical bone.
    Yan J; Sun W; Zhang J; Goltzman D; Miao D
    Am J Pathol; 2012 Jul; 181(1):234-44. PubMed ID: 22640808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of the transcriptional factor Runx2 in osteoblasts abolishes the anabolic effect of parathyroid hormone in vivo.
    Merciris D; Marty C; Collet C; de Vernejoul MC; Geoffroy V
    Am J Pathol; 2007 May; 170(5):1676-85. PubMed ID: 17456773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective Runx2-II deficiency leads to low-turnover osteopenia in adult mice.
    Xiao Z; Awad HA; Liu S; Mahlios J; Zhang S; Guilak F; Mayo MS; Quarles LD
    Dev Biol; 2005 Jul; 283(2):345-56. PubMed ID: 15936013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parathyroid hormone: anabolic and catabolic actions on the skeleton.
    Silva BC; Bilezikian JP
    Curr Opin Pharmacol; 2015 Jun; 22():41-50. PubMed ID: 25854704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MMP14 is a novel target of PTH signaling in osteocytes that controls resorption by regulating soluble RANKL production.
    Delgado-Calle J; Hancock B; Likine EF; Sato AY; McAndrews K; Sanudo C; Bruzzaniti A; Riancho JA; Tonra JR; Bellido T
    FASEB J; 2018 May; 32(5):2878-2890. PubMed ID: 29401593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.